» Go to news main
Molly Appeal paves the way to precision cancer treatment
A group of Dalhousie Medical School researchers is spearheading a new initiative to develop personalized cancer treatments, with support from Dalhousie Medical Research Foundation’s 2017-18 Molly Appeal.
“Every person’s cancer is as unique as their fingerprints,” says Dr. Paola Marignani, an internationally known cancer researcher and professor in Dalhousie’s Department of Biochemistry & Molecular Biology who’s leading this year’s Molly Appeal research initiative.
Read more on Dal News.
Recent News
- New health researchers at Dal, IWK and Nova Scotia Health receive funding from Research Nova Scotia
- Regally recognized: Dal faculty named to the Order of Canada
- Pop‑ups for the greater good: Dal doctor spearheads on‑campus rapid‑testing site
- James R. Johnston Chair Launches Black Analysis Lecture Series
- Not your average PUPPY: Research to support better primary care during a pandemic
- New federal funding elevates Dal's capacity to tackle COVID‑19 pandemic
- Family Medicine
- Putting Health First at Dalhousie During a Difficult Year